In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

Therapeutic Proteins

PharmaNet Consulting professionals can assist you with many aspects of developing laboratory-engineered therapeutic proteins and biosimilar products. PharmaNet professionals call on their experience as senior-level FDA officials to offer advice on every stage of the regulatory process, from planning a Biologics License Application (BLA) for biological products to establishing a post-marketing registry to track product safety.

 

PharmaNet professionals available for consultation on this topic include:

 

Andrew Chang, PhD

Executive Director, PharmaNet Consulting


William M. Egan, PhD

Executive Director, PharmaNet Consulting


Joyce Lea Frey-Vasconcells, PhD

Executive Director, PharmaNet Consulting

 

Duu-Gong Wu, PhD

Executive Director, PharmaNet Consulting

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390